Are you Dr. D'Andrea?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2910 Toll Gate Dr
East Norriton, PA 19403Phone+1 610-631-2652
Summary
- Dr. Denise D'Andrea, MD is a nephrologist in East Norriton, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, Alabama, and California.
Education & Training
- University of Pennsylvania Health SystemFellowship, Nephrology, 1993 - 1994
- University of Pennsylvania Health SystemFellowship, Nephrology, 1991 - 1992
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1989 - 1990
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1987 - 1989
- Georgetown University School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1990 - Present
- NJ State Medical License 1988 - 2025
- PA State Medical License 1990 - 2024
- MD State Medical License 1990 - 1992
- NY State Medical License 1990 - 1992
- OH State Medical License 1990 - 1992
- AL State Medical License 1991 - 1991
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 114 citationsSafety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Re...C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee
Circulation. 2016-12-13 - 87 citationsCSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy SubjectsAndreas Gille, Rachael Easton, Denise D'Andrea, Samuel D. Wright, Charles L. Shear
Arteriosclerosis, Thrombosis, and Vascular Biology. 2014-09-01 - 10 citationsEvaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.Paul A. Gurbel, Udaya S. Tantry, Denise D'Andrea, Thomas Chung, John H. Alexander
Journal of Thrombosis and Thrombolysis. 2018-05-01
Professional Memberships
- Fellow